- 123.5k views
Biosimilars and Cancer Supportive Care
Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing approved reference biologic drug. In cancer supportive care, biosimilars have become increasingly important for managing various aspects of cancer treatment, including supportive therapies. One significant application of biosimilars in cancer supportive care is in the management of chemotherapy-induced neutropenia. Neutropenia, characterized by low levels of neutrophils (a type of white blood cell), is a common side effect of chemotherapy that can increase the risk of infections. Biosimilar versions of granulocyte colony-stimulating factors (G-CSFs), such as filgrastim and pegfilgrastim, are used to stimulate the production of neutrophils and reduce the duration and severity of neutropenia.
About the Speaker
Dr. Abdul Rahman Agha El Kinge
HOD Hematology Oncology, Fakeeh University Hospital, DXB
Upcoming Case Discussions
Conversational AI: Redefining Physician Documentation and Patient Care
Dr. Sandeep Wadhwa is a distinguished healthcare executive with extensive experience in both clinical medicine and healthcare innovation. He currently serves as the Global Chief Medical Officer at Solventum, a position he has held since October 2020, where he leads the company's medical initiatives. Additionally, Dr. Wadhwa is an Associate Clinical Professor of Medicine at the University of Colorado Health Sciences Center, a role he has held for over 26 years, contributing to both education and clinical excellence. Prior to his current position, Dr. Wadhwa was the Chief Health Officer & SVP of Market Innovation at Solera Health, where he focused on addressing chronic disease and improving health outcomes through innovative community and digital health solutions. His previous leadership roles include SVP of Product Management and CMO at Noridian Healthcare Solutions and CMO & Business Unit Vice President at 3M Health Information Systems. Dr. Wadhwa earned his MD from Joan & Sanford I. Weill Medical College of Cornell University and an MBA from The Wharton School, blending medical expertise with business acumen to drive impactful healthcare strategies.
Alpha Lipoic Acid: Pharmacokinetics & Applications
Alpha-lipoic acid (ALA) is a naturally occurring antioxidant involved in mitochondrial energy metabolism. It is rapidly absorbed in the gastrointestinal tract and distributed throughout the body, with high concentrations in the liver and kidneys. ALA is both water- and fat-soluble, allowing it to neutralize free radicals in various environments. It undergoes extensive hepatic metabolism and is excreted primarily via the urine. ALA has therapeutic applications in managing conditions like diabetes, neurodegenerative diseases, and as a supplement for its antioxidant benefits.
Hyperlipidemia: From Diagnosis to Treatment
Hyperlipidemia is a condition characterized by elevated levels of lipids, such as cholesterol and triglycerides, in the blood, which can increase the risk of cardiovascular diseases. Diagnosis typically involves blood tests measuring lipid profiles, while treatment focuses on lifestyle changes, such as diet and exercise, alongside medications like statins to manage cholesterol levels and reduce cardiovascular risk. Regular monitoring is essential for effective management and prevention of complications.
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Role of AI in Diabetes Care & Metabolic Wellness
AI is increasingly playing a significant role in diabetes care and metabolic wellness by enhancing early detection, personalized treatment, and continuous monitoring. Machine learning algorithms analyze patient data, such as glucose levels and lifestyle factors, to provide more accurate predictions and tailored management plans. AI-powered tools, like smart insulin pumps and continuous glucose monitors, help patients track their condition in real time, improving outcomes and reducing complications. Additionally, AI assists healthcare providers in identifying trends, optimizing treatment strategies, and enabling more proactive care for individuals with diabetes or metabolic disorders.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Abdul Rahman Agha El Kinge's Talks on Assimilate
- 0
Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing approved reference biologic drug. In cancer supportive care, biosimilars have become increasingly important for managing various aspects of cancer treatment, including supportive therapies. One significant application of biosimilars in cancer supportive care is in the management of chemotherapy-induced neutropenia. Neutropenia, characterized by low levels of neutrophils (a type of white blood cell), is a common side effect of chemotherapy that can increase the risk of infections. Biosimilar versions of granulocyte colony-stimulating factors (G-CSFs), such as filgrastim and pegfilgrastim, are used to stimulate the production of neutrophils and reduce the duration and severity of neutropenia.
- 0
Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing approved reference biologic drug. In cancer supportive care, biosimilars have become increasingly important for managing various aspects of cancer treatment, including supportive therapies. One significant application of biosimilars in cancer supportive care is in the management of chemotherapy-induced neutropenia. Neutropenia, characterized by low levels of neutrophils (a type of white blood cell), is a common side effect of chemotherapy that can increase the risk of infections. Biosimilar versions of granulocyte colony-stimulating factors (G-CSFs), such as filgrastim and pegfilgrastim, are used to stimulate the production of neutrophils and reduce the duration and severity of neutropenia.